Editorial: Molecular informatics in personalized medicine, volume II
-
By
-
J. Francis Borgio
-
Hari S. Sharma
-
Noor B. Almandil
-
Sayed AbdulAzeez
-
Peter J. van der Spek
-
May 28, 2026
-
Clinical Scorecard: Advancements in Molecular Informatics for Tailored Medicine, Volume II
At a Glance
| Category | Detail |
|---|
| Condition | Personalized Medicine |
| Key Mechanisms | Integration of high-throughput data, genomic long-reads, metabolomic profiles, immunoinformatics, and metagenomics. |
| Target Population | Patients with complex diseases such as prostate cancer, cardiovascular disease, metabolic syndromes, and infectious diseases. |
| Care Setting | Clinical settings utilizing advanced molecular diagnostics. |
Key Highlights
- Long-read sequencing improves diagnostic accuracy for genetic testing.
- Metabolomics distinguishes between familial and non-genetic hypercholesterolemia.
- Immunoinformatics aids in developing multi-epitope vaccines for prostate cancer.
- Metagenomic sequencing enhances diagnosis in immunocompromised patients.
- Circulating microRNAs may serve as early indicators of Type 2 Diabetes.
Guideline-Based Recommendations
Diagnosis
- Utilize long-read sequencing for complex genomic regions.
- Employ metabolomics to differentiate between types of hypercholesterolemia.
Management
- Implement targeted therapies for familial hypercholesterolemia.
- Optimize antimicrobial therapy based on rapid molecular identification.
Monitoring & Follow-up
- Monitor dysregulated microRNAs in pre-diabetic individuals.
Risks
- Consider the implications of tumor heterogeneity and immune evasion in cancer treatment.
Patient & Prescribing Data
Individuals with complex diseases requiring personalized treatment strategies.
Advanced therapies may include targeted vaccines and metabolic interventions.
Clinical Best Practices
- Incorporate multi-omics data for precision medicine.
- Utilize rapid genomic tools for timely diagnosis and treatment adjustments.
Related Resources & Content
